Advertisement
Research Article| Volume 30, ISSUE 7, 105787, July 2021

Download started.

Ok

Inflammatory Bowel Disease as a Precondition for Stroke or TIA: A Matter of Crohn's Disease Rather than Ulcerative Colitis

      Abstract

      Background

      As a chronic systemic inflammation may be associated with an increased risk of vascular events, the aim of the present study was to assess the incidence of stroke and transient ischemic attack (TIA) in patients with inflammatory bowel disease over a period of 15 years.

      Methods

      This cohort study included patients for whom the initial diagnosis of an inflammatory bowel disease (IBD) (Crohn's disease: CD and ulcerative colitis: UC) was documented anonymously between 2000 and 2015 in 1,262 general practices in Germany. IBD patients were matched to patients without IBD using propensity scores based on age, sex, physician, co-diagnoses and co-therapies. Cox regression models were used to study the incidence of stroke and TIA as a function of CD and UC.

      Results

      Each of the matched groups included 11,947 participants. In the IBD group, 43.5% had CD and 56.5% UC respectively. Higher incidences of both stroke and TIA were detected for IBD (stroke: 279.0 versus 222.6 cases per 100,000 patient years, HR 1.30, p=0.011; TIA: 203.1 versus 141.1 cases per 100,000 patient years, HR 1.42, p=0.006). Stroke and TIA incidences (cases per 100,000 patient years) were higher than in controls (stroke: 314.7 versus 204.5, HR: 1.50, p=0.013; TIA: 183.8 versus 95.3, HR: 1.93, p=0.004) in CD patients only. No relevant differences in incidences were found for patients with UC.

      Conclusion

      While CD turned out to be a relevant precondition for stroke or TIA, this was not the case for UC.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hansson GK.
        Inflammation, atherosclerosis, and coronary artery disease.
        N Engl J Med. 2005; 352: 1685-1695
        • Piazza G
        • Goldhaber SZ.
        Venous thromboembolism and atherothrombosis: an integrated approach.
        Circulation. 2010; 121: 2146-2150
        • Choi YJ
        • Lee DH
        • Shin DW
        • Han KD
        • Yoon H
        • Shin CM
        • Park YS
        • Kim N.
        Patients with inflammatory bowel disease have an increased risk of myocardial infarction: a nationwide study.
        Aliment Pharmacol Ther. 2019; 50: 769-779
        • Bigeh A
        • Sanchez A
        • Maestas C
        • Gulati M.
        Inflammatory bowel disease and the risk for cardiovascular disease: does all inflammation lead to heart disease?.
        Trends Cardiovasc Med. 2019; : 10
        • Wu P
        • Jia F
        • Zhang B
        • Zhang P.
        Risk of cardiovascular disease in inflammatory bowel disease.
        Exp Ther Med. 2017; 13: 395-400
        • Kristensen SL
        • Lindhardsen J
        • Ahlehoff O
        • Erichsen R
        • Lamberts M
        • Khalid U
        • Torp-Pedersen C
        • Nielsen OH
        • Gislason GH
        • Hansen PR.
        Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study.
        Europace. 2014; 16: 477-484
        • Card TR
        • Zittan E
        • Nguyen GC
        • Grainge MJ.
        Disease activity in inflammatory bowel disease is associated with arterial vascular disease.
        Inflamm Bowel Dis. 2020; : izaa156
        • Singh S
        • Singh H
        • Loftus Jr., EV
        • Pardi DS
        Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis.
        Clin Gastroenterol Hepatol. 2014; 12: 382-393
        • Xiao Z
        • Pei Z
        • Yuan M
        • Li X
        • Chen S
        • Xu L.
        Risk of stroke in patients with inflammatory bowel disease: a systematic review and meta-analysis.
        J Stroke Cerebrovasc Dis. 2015; 24: 2774-2780
        • Yuan M
        • Zhou HY
        • Xiao XL
        • Wang ZQ
        • Yao Z
        • Yin XP.
        Inflammatory bowel disease and risk of stroke: a meta-analysis of cohort studies.
        Int J Cardiol. 2016; 202: 106-109https://doi.org/10.1016/j.ijcard.2015.08.190
        • Bernstein CN
        • Wajda A
        • Blanchard JF.
        The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study.
        Clin Gastroenterol Hepatol. 2008; 6: 41-45
        • Rathmann W
        • Bongaerts B
        • Carius HJ
        • Kruppert S
        • Kostev K.
        Basic characteristics and representativeness of the German Disease Analyzer database.
        Int J Clin Pharmacol Ther. 2018; 56: 459-466
        • Odze R.
        Diagnostic problems and advances in inflammatory bowel disease.
        Mod Pathol. 2003; 16: 347-358
        • Luna JM
        • Moon YP
        • Liu KM
        • Spitalnik S
        • Paik MC
        • Cheung K
        • Sacco RL
        • Elkind MS.
        High-sensitivity C-reactive protein and interleukin-6-dominant inflammation and ischemic stroke risk: the northern Manhattan study.
        Stroke. 2014; 45: 979-987
        • Card TR
        • Zittan E
        • Nguyen GC
        • Grainge MJ.
        Disease activity in inflammatory bowel disease is associated with arterial vascular disease.
        Inflamm Bowel Dis. 2020; : izaa156
        • Rolfs A
        • Fazekas F
        • Grittner U
        • Dichgans M
        • Martus P
        • Holzhausen M
        • Böttcher T
        • Heuschmann PU
        • Tatlisumak T
        • Tanislav C
        • Jungehulsing GJ
        • Giese AK
        • Putaala J
        • Huber R
        • Bodechtel U
        • Lichy C
        • Enzinger C
        • Schmidt R
        • Hennerici MG
        • Kaps M
        • Kessler C
        • Lackner K
        • Paschke E
        • Meyer W
        • Mascher H
        • Riess O
        • Kolodny E
        • Norrving B.
        Acute cerebrovascular disease in the young: the stroke in Young Fabry patients study.
        Stroke. 2013; 44: 340-349
        • von Sarnowski B
        • Putaala J
        • Grittner U
        • Gaertner B
        • Schminke U
        • Curtze S
        • Huber R
        • Tanislav C
        • Lichy C
        • Demarin V
        • Basic-Kes V
        • Ringelstein EB
        • Neumann-Haefelin T
        • Enzinger C
        • Fazekas F
        • Rothwell PM
        • Dichgans M
        • Jungehulsing GJ
        • Heuschmann PU
        • Kaps M
        • Norrving B
        • Rolfs A
        • Kessler C
        • Tatlisumak T.
        Lifestyle risk factors for ischemic stroke and transient ischemic attack in young adults in the Stroke in Young Fabry patients study.
        Stroke. 2013; 44: 119-125
        • Tanislav C
        • Grittner U
        • Misselwitz B
        • Jungehuelsing GJ
        • Enzinger C
        • SB von
        • Putaala J
        • Kaps M
        • Kropp P
        • Rolfs A
        • Tatlisumak T
        • Fazekas F
        • Kolodny E
        • Norrving B.
        Lessons from everyday stroke care for clinical research and vice versa: comparison of a comprehensive and a research population of young stroke patients.
        BMC Neurol. 2014; 14: 45https://doi.org/10.1186/1471-2377-14-45
        • Romberg-Camps MJ
        • Dagnelie PC
        • Kester AD
        • Hesselink-van de Kruijs MA
        • Cilissen M
        • Engels LG
        • Van DC
        • Hameeteman WH
        • Wolters FL
        • Russel MG
        • Stockbrägger RW.
        Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
        Am J Gastroenterol. 2009; 104: 371-383
        • Grainge MJ
        • West J
        • Card TR.
        Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study.
        Lancet. 2010; 375: 657-663
        • Shaw LJ
        • Bugiardini R
        • Merz CN.
        Women and ischemic heart disease: evolving knowledge.
        J Am Coll Cardiol. 2009; 54: 1561-1575
        • Carlton C
        • Banks M
        • Sundararajan S.
        Oral contraceptives and ischemic stroke risk.
        Stroke. 2018; 49: e157-e159
        • Madsen TE
        • Khoury JC
        • Alwell K
        • Moomaw CJ
        • Rademacher E
        • Flaherty ML
        • Woo D
        • La Rosa FLR
        • Mackey J
        • Martini S
        • Ferioli S
        • Adeoye O
        • Khatri P
        • Broderick JP
        • Kissela BM
        • Kleindorfer D
        Temporal trends of sex differences in transient ischemic attack incidence within a population.
        J Stroke Cerebrovasc Dis. 2019; 28: 2468-2474
        • Mackner LM
        • Vannatta K
        • Crandall WV.
        Gender differences in the social functioning of adolescents with inflammatory bowel disease.
        J Clin Psychol Med Settings. 2012; 19: 270-276